Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on chiral catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114160206B reveals a novel chiral copper catalyst enabling high-yield, enantioselective synthesis of indole pharmaceutical intermediates with superior purity.
Novel organocatalytic route for high-purity axial chiral indole-naphthalenes. Cost-effective, scalable process for asymmetric catalysis intermediates.
Novel chiral phosphoric acid catalyzed resolution method for axially chiral oxindole-substituted styrenes. High ee values up to 96%. Ideal for pharma intermediates.
Novel axial chiral bisindole catalysts for asymmetric synthesis. Superior stereoselectivity and mild conditions for pharmaceutical intermediates manufacturing.
This patent introduces a novel axial chiral naphthalene-pyrrole phosphine catalyst with mild reaction conditions and high enantioselectivity, enabling cost-effective production of chiral intermediates for pharmaceutical applications.
Breakthrough rhodium-catalyzed method enables high-yield synthesis of axichiral dienes with up to 95% ee, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Breakthrough axial chiral catalyst enables high-purity API intermediates with enhanced stereoselectivity and scalable manufacturing advantages.
Patent CN118878543A enables high-yield synthesis of chiral compounds with exceptional enantioselectivity exceeding 99% ee under mild conditions driving cost reduction in pharmaceutical manufacturing while ensuring supply chain reliability.
Breakthrough chiral biaryl pyridoxamine catalyst enables high-yield asymmetric transamination with mild conditions, offering reliable supply chain for pharmaceutical intermediates.
Patent CN115215779B enables efficient synthesis of chiral spirocyclic catalysts with simplified routes and high yield for reliable fine chemical supply chains.
Discover a scalable, cost-effective synthesis method for indolocyclopentane compounds with >95% yield and 93% ee. Ideal for pharmaceutical R&D and production of prostate cancer therapeutics.
Discover N-N axis chiral indole-pyrrole synthesis with 97% ee, reducing R&D costs and supply chain risks for asymmetric pharmaceutical catalysts.
Discover a scalable, high-ee synthesis method for N-N axis chiral indole-pyrrole compounds. Ideal for chiral catalyst development with 97% ee and 62% yield. Reduce R&D costs and supply chain risks.
Discover how chiral phase transfer catalysis enables 92% ee and 80% yield in axial chiral isopyrone-indole synthesis for potent PC-3 tumor activity. Scale-ready for pharma R&D.
Solve chiral synthesis challenges with this one-pot two-step method. Achieve 95% ee, 80-89% yield, and simplified production for pharmaceutical intermediates.
Solve supply chain risks in chiral synthesis with this novel protonic acid catalyst. Achieve 98% ee and 96% yield in ruthenium-catalyzed reactions. Contact us for custom synthesis.
Solve chiral synthesis challenges with 93% yield and 98:2 er. Our CDMO expertise scales this patent-protected method for stable API supply chains.
Solve high-cost chiral catalyst production with 99.5% ee, 80% yield, and no toxic reagents. Scale to 100MT/yr with NINGBO INNO PHARMCHEM.
Reduce production costs by 30% with this catalyst achieving >95% ee in asymmetric reactions. Ideal for pharma R&D and procurement teams.
Solve chiral induction challenges with 97% yield axial diamine synthesis. Reduce R&D costs & scale production for pharma intermediates.